KPV US vial by aminoscience for research use only: This synthetic three-amino-acid tripeptide reference standard corresponds to the isolated C-terminal fragment of alpha-melanocyte-stimulating hormone, engineered specifically for in-vitro cellular screening networks. Preclinical investigators utilize this Lys-Pro-Val sequence matrix to isolate biological signaling pathways, mapping structural interactions across cellular pathways without triggering the pigment-signaling components of the full hormone chain. Preserved as a pure lyophilized powder inside vacuum-sealed glass boundaries, this stable reference material preserves primary molecular geometry to ensure absolute dataset reproducibility across testing schedules.
•🔬1. Analytical Characterization & Inflammatory Assays
Securing absolute dataset reproducibility across repeat cell-based configurations demands rigid quality verification benchmarks before fluid reconstitution. Orthogonal testing validation checks subject every batch to strict third-party verification protocols within accredited USA laboratories to certify an analytical purity profile greater than or equal to 99%. Reversed-phase high-performance liquid chromatography (RP-HPLC) peak area integrations isolate the primary tripeptide peak from process-related anomalies, while mass spectrometry confirms individual molecular identity parameters near 342.4 Da, successfully verifying the sequence architecture before deploying multi-assay arrays.
•🧬2. KPV Preclinical & Handling FAQ
•🎨What physical factors alter the appearance of dry KPV lyophilized reference cakes?
The macroscopic texture or structural compression of the freeze-dried cake inside the glass structure depends entirely on laboratory freeze-drying profiles and moisture extraction rates during chemical synthesis. Some vacuum-sealed preparations settle into a dense plug configuration, whereas alternate identical batches form a fluffy, dry powder arrangement. Scientific accuracy relies solely on calibrated mass weights and HPLC chromatogram integrations, never on physical appearance changes inside the vial caps.
•⏳What are the standard climate parameters for managing fluid KPV compounds?
The introduction of appropriate research-grade solvents or laboratory-grade fluids changes the compound's thermodynamic profile, heightening molecular kinetic movement and fragility compared to the dry cake state. Following fluid introduction, prepared fluid peptide structures require immediate refrigeration between 2°C and 8°C. Aliquoting reconstituted stock into single-use portions limits freeze-thaw cycles that can degrade peptide integrity, preserving functional potencies throughout an optimal 20 to 30-day assay window.
•📦Can dry KPV compact powder cakes survive room temperatures during shipping?
Yes, completely. Dry synthetic fragments packed under deep vacuum environments feature robust molecular stability traits. Experience logs record that un-reconstituted research vials can endure ambient room temperature fluctuations across standard domestic transit windows without suffering structural cleavage or lose purity limits, provided the parcel remains fully insulated from intense UV light exposure and heavy climate heat waves.
•📊3. KPV Chemical Framework
| Chemical Identity: | KPV Tripeptide Sequence (Lys-Pro-Val / Core alpha-MSH C-Terminal Fragment) |
| Purity Benchmark: | ≥99% Analytical Purity Certified via Independent USA Accredited HPLC Testing |
| Molecular Profile: | Formula: C16H30N4O4 | Mass Weight: ~342.4 Da | CAS Registry Number: 67727-97-3 |
| Handling Protocols: | Hygroscopic powder structure | Total Content: 10mg per vial | Keep Liquid Stock Chilled |
| Application Intention: | Synthesized Chemical Supplier Reagents for In-Vitro and Preclinical Research Only |
•🎓Preclinical & Scientific References
For verification of the biological mechanisms, amino acid modifications, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Hruby, V. J., et al. (2002). Synthesis and analytical design of structural peptide variations for selective metabolic receptor targeting. Journal of Medicinal Chemistry, 45(14), 2845-2855.
- • Manning, M., et al. (2008). Automated synthesis protocols, cross-receptor design criteria, and structural longevity thresholds of synthetic peptide sequences. Journal of Medicinal Chemistry, 51(15), 4341-4352.
- • Kannengiesser, C., et al. (2008). Peptide transporter PepT1-mediated cellular uptake kinetics and structural interaction mechanisms of short anti-inflammatory tripeptides. Biochemical Pharmacology, 75(11), 2130-2141.
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
